For licensed medical professionals and compounding pharmacies only. Not for sale to the general public.  ·  787-822-8197
Product sourcing reference

Pinealon

Pinealon is a short bioregulator tripeptide from Russian gerontology research. Evidence is limited and largely from a single research tradition.

Reference variants

Add Pinealon to an order request

Quantities are individual vials (packs of 10). Orders need 100 vials and/or 20 spray bottles in total, mixed across items. Prices are reference estimates captured 2026-10-16; every request is pending eligibility and availability review. Per-unit figures are rounded to the cent from kit pricing, so a final quote may differ slightly.

  • 10mgVial · confirm physical formCAS 175175-23-2
    $14.38/vial$11.50/vial at 1,000+ vials of this item
    vials, packs of 10

Review your order request · Compare the full catalog

Confirm the exact substance

The listed sequence is Glu-Asp-Arg. Short peptides like this can be hard to distinguish analytically from related impurities; request identity data.

What the review will ask

There is no approved product. Record intended use and avoid relying on neuroprotective claims.

  • State the facility type, destination state and intended transaction. Do not send patient information.
  • Expect product- and lot-specific documentation to be requested before any material is accepted.
  • A listed price is a reference estimate. Availability, labeling, shipping and terms are confirmed in writing only after review.

Purchasing questions

Is pinealon related to epithalon?

Both come from the same bioregulator research programme but have different sequences and claims.

Require a sequence-specific comparison

The listing's Pinealon name should be matched to a documented sequence, not to another short peptide with similar marketing. A bioregulator category is not an approval category.

Documentation to request

Ask for sequence identity, analytical methods and the actual studies cited for this material. Do not transfer claims from epithalon.

Regulatory context: FDA: compounding, approval and quality standards. Source reviewed . This source does not verify the identity, testing or availability of our catalog references.

Related guidance: Non-clinical protocol review checklist. These references support a review, not a treatment recommendation or supply authorization.

Verify the current regulatory position

Use FDA human drug compounding guidance and applicable state requirements. This reference is not medical or legal advice and does not establish a lawful supply route.

Discuss sourcing requirements
Call Apply for Wholesale